Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis.
about
Immunology of hepatocellular carcinomaThe frequency of CCR5 promoter polymorphisms and CCR5 Δ 32 mutation in Iranian populations.Chemokines and their receptors play important roles in the development of hepatocellular carcinomaSerum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinomaCCR2 and CCR5 genes polymorphisms in women with cervical lesions from Pernambuco, Northeast Region of Brazil: a case-control study.Chemokines and hepatocellular carcinoma.Chemokine-chemokine receptors in cancer immunotherapy.Is the CCR5 Δ 32 mutation associated with immune system-related diseases?Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis.Meta-analysis of MCP-1 promoter -2518 A/G polymorphism and SLE susceptibility.Lack of Correlation Between the CCR5-Δ32 Mutation and Acute Myeloid Leukemia in Iranian Patients.CCR5 Δ 32 mutation is not prevalent in Iranians with chronic HBV infection.Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients.Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma.Genetic polymorphisms in ataxin-3 and liver cirrhosis risk related to aflatoxin B1.
P2860
Q26795411-16DD4D39-F7AD-4AC5-99B4-4D61ABBEEC4CQ35630456-230CB9A1-928F-49CE-87DF-EC29FB63664EQ35668771-CFB98DC7-824A-4495-8CB8-C2F3AC4135ACQ35744895-6125E4B3-57AE-491C-A5EA-082C48B6E1FCQ36720252-A9520D85-85D7-40E7-9593-32B9103EAE2DQ37732087-B4427FCF-1164-4BA3-A586-99CD7A3DA682Q37773282-A9F1D03B-5709-4E11-BAE8-AE24BCC87273Q38068379-1151C9E7-A12E-49C9-B6E3-E70D2C8BE8ACQ38235254-D56FCF07-570C-4EC3-8C22-A819B9311A6EQ38415708-4DBC0D5D-7671-4297-8BC5-57F35400A0F8Q41576643-0DC8D584-0501-4378-BD20-DB284CB5B6E6Q44641632-5FD8AB3F-4A95-4D4A-BD8A-3EFECD1870EBQ47148111-9F678F69-151C-4372-9245-8588D6420B50Q51748031-B15901AB-4FD7-4002-8728-6DBA86E90D8EQ55261033-57E317D3-2F35-4194-85ED-71B1F52E18C5
P2860
Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemokine system polymorphisms ...... tis C virus-related cirrhosis.
@en
Chemokine system polymorphisms ...... tis C virus-related cirrhosis.
@nl
type
label
Chemokine system polymorphisms ...... tis C virus-related cirrhosis.
@en
Chemokine system polymorphisms ...... tis C virus-related cirrhosis.
@nl
prefLabel
Chemokine system polymorphisms ...... tis C virus-related cirrhosis.
@en
Chemokine system polymorphisms ...... tis C virus-related cirrhosis.
@nl
P2093
P2860
P50
P356
P1476
Chemokine system polymorphisms ...... itis C virus-related cirrhosis
@en
P2093
Chantal Simon
Jean-Claude Trinchet
Liliane Gattegno
Michel Beaugrand
Pierre Rufat
P2860
P304
P356
10.3748/WJG.14.713
P407
P577
2008-02-01T00:00:00Z